Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, ...
Only four months after IO Biotech decided to halve its head count, the Danish biotech is already considering whether it must ...
Investing.com -- IO Biotech Inc (NASDAQ:IOBT) stock plunged 46.5% Wednesday after the clinical-stage biopharmaceutical company announced it would explore strategic alternatives to maximize stockholder ...
It takes a bit more time to set up, but it's worth it ...